Andy J. Lau

ANDY LAU focuses his practice on advising public and private companies and investment funds on tax aspects of public and private mergers, and equity and asset acquisitions and dispositions. Andy also has broad experience in advising clients on tax aspects relating to structured finance, securitization, and fund formation.

Prior to joining Sidley, Andy was a tax associate at another global law firm in Philadelphia.

Andy holds a J.D. from Vanderbilt University, where he served as the executive development editor of the Vanderbilt Journal of Transactional Law.

• New Catalyst Strategic Partners (New Catalyst) in its first strategic partnership, launched with Ironleaf Capital.
• Bonaccord Capital Partners in its passive minority investment in Kingswood Capital Management, LP.
• BDT & MSD Partners in connection with their pending AU$1.6 billion investment in DBG Health, a leading Australian beauty and pharmaceutical company.
• Sagard Healthcare Partners in providing up to US$250 million in non-dilutive financings to Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology.
• Funds managed by affiliates of Apollo in the acquisition of the Environmental Services business of GFL Environmental Inc.
• Tenneco Inc., a portfolio company of funds managed by affiliates of Apollo Global Management, Inc., in its sale of Öhlins Racing to Brembo.
• Funds advised by Wafra Inc. in the pending acquisition of Aquila Air Capital from funds managed by Warburg Pincus LLC.